Point72 Asia (Singapore)’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$25.7K	Sell	2,330 -3,715	-61%	-$41K	﹤0.01%	698
2025 Q1	$54K	Buy	+6,045	New	+$54K	0.01%	564
2024 Q3	–	Sell	-9,057	Closed	-$76.8K	–	1311
2024 Q2	$76.8K	Sell	9,057 -2,749	-23%	-$23.3K	0.02%	548
2024 Q1	$106K	Buy	+11,806	New	+$106K	0.03%	629